Alexander Prattes
General Practice · Mission Viejo, CANPI 1144318346
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 139 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 15.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $3,427 and has fallen 99.6% since, to $15 in 2025. Among general practice clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 139 payments — averaging $40.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$894
- Amarin Pharma, Inc.$717
- Lilly USA, LLC$684
- Novo Nordisk$632
- Kowa Pharmaceuticals America, Inc.$390
- Bayer$330
- plus $2K from 13 others
What the payments were for
- Food & beverage$5,61199%
- Education$331%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 22 | $894 |
| Amarin Pharma, Inc. | 13 | $717 |
| Lilly USA, LLC | 22 | $684 |
| Novo Nordisk | 16 | $632 |
| Kowa Pharmaceuticals America, Inc. | 19 | $390 |
| Bayer | 9 | $330 |
| Boehringer Ingelheim | 7 | $275 |
| Amgen | 3 | $270 |
| AbbVie(2 entities) | 4 | $250 |
| Novartis | 8 | $235 |
| Johnson & Johnson | 4 | $214 |
| Esperion Therapeutics, Inc. | 2 | $208 |
| Astellas Pharma US Inc | 3 | $167 |
| Daiichi Sankyo Inc. | 2 | $105 |
| Bristol Myers Squibb | 1 | $105 |
| Biotronik Inc. | 1 | $93 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $34 |
| GSK | 1 | $24 |
| Livanova USA, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,644 in reported general payments places this provider in the 95th percentile of 12,963 general practice providers in California.
Other general practice in Mission Viejo
- Nathan LiLancaster$5.2M
- Milton McCollSan Jose$4.9M
- Frederic MollRedwood City$2.5M
- Bradley ChingUpland$1.4M
- Eric BrassTorrance$755K
- Marc GeissbergerGreenbrae$583K
- Robert CampbellLong Beach$501K
- Varo BoyerNorth Hills$482K
- Michael MiyasakiSacramento$464K
- Apolinar MadrigalCeres$419K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.